摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

二丁基亚磷酸氢酯 | 109-47-7

中文名称
二丁基亚磷酸氢酯
中文别名
——
英文名称
dibutyl hydrogen phosphite
英文别名
dibutyl phosphite
二丁基亚磷酸氢酯化学式
CAS
109-47-7
化学式
C8H19O3P
mdl
——
分子量
194.211
InChiKey
UZEFVQBWJSFOFE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    12
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2920901900

SDS

SDS:65829be80c87ac8bc44fb7d01b359004
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Tandem Claisen Condensation/Transesterification between Arylacetate Enolates and Arylmethylene-Substituted 2,2-Dimethyl-1,3-dioxolan-4-ones: An Improved Synthesis of Z-Configured Pulvinones
    摘要:
    用新型膦酸盐 24b 对芳香醛进行霍纳-沃兹沃斯-埃蒙斯(HWE)烯化反应,可得到 E 构型的芳基亚甲基取代的 2,2-二甲基-1,3-二氧戊环-4-酮 25a-f(收率为 79-88%)。后者与芳基乙酸甲酯锂烯醇化物 lithio-20b-d 发生缩合,经酸处理和结晶后得到异构纯 (Z)-pulvinones 8d-s,收率为 75-91%。我们还发现,膦酸盐 24b 与脂肪族醛之间的 Horner-Wadsworth-Emmons 反应可生成 E 型烷基亚甲基取代的 2,2-二甲基-1,3-二氧戊环-4-酮 25g-i(收率为 82-96%)。
    DOI:
    10.1055/s-2006-950378
  • 作为产物:
    描述:
    磷酸二丁酯吡啶亚磷酸二乙酯 作用下, 以 乙醚 为溶剂, 生成 二丁基亚磷酸氢酯
    参考文献:
    名称:
    Michalski,J.; Modro,T., Chemische Berichte, 1962, vol. 95, p. 1629 - 1636
    摘要:
    DOI:
  • 作为试剂:
    描述:
    参考文献:
    名称:
    Harger, Martin J. P., Journal of the Chemical Society. Perkin transactions II, 1980, p. 154 - 160
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME
    申请人:OTSUKA CHEMICAL CO., LTD.
    公开号:US20170233421A1
    公开(公告)日:2017-08-17
    An object of the present invention is to provide a crystal of a cyclic phosphonic acid sodium salt (2ccPA) with high purity and excellent storage stability and a method for producing the crystal. The present invention provides a crystal of a cyclic phosphonic acid sodium salt (2ccPA) represented by formula (1):
    本发明的目的是提供一种具有高纯度和优异储存稳定性的环磷酸钠盐晶体(2ccPA)以及制备该晶体的方法。本发明提供了一种由化学式(1)表示的环磷酸钠盐(2ccPA)的晶体:
  • [EN] OLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID OLEIC ACID DERIVATIVES, AND THEIR USES<br/>[FR] DÉRIVÉS D'ACIDE OLÉIQUE, COMPOSITION PHARMACEUTIQUE OU COMPOSITION ALIMENTAIRE COMPRENANT LESDITS DÉRIVÉS D'ACIDE OLÉIQUE, ET LEURS UTILISATIONS
    申请人:UNIV BOURGOGNE
    公开号:WO2019228994A1
    公开(公告)日:2019-12-05
    This invention relates to oleic acid derivative comprising a hydrophobic part C17H33 linked to a particular polar head part "A", especially for use as a medicament, for instance, for the treatment of a disorder caused by the GPR120 receptor and/or the CD36 receptor, comprising administering to a subject in need thereof a therapeutically effective amount of said oleic acid derivative or of said pharmaceutical composition. The invention also relates to the use of said oleic acid derivative as a food composition.
    这项发明涉及一种油酸生物,其中包括一个与特定极性头部"A"连接的疏部分C17H33,特别用作药物,例如,用于治疗由GPR120受体和/或CD36受体引起的疾病,包括向需要的受试者施用所述油酸生物或所述药物组合的治疗有效量。该发明还涉及将所述油酸生物用作食品组成的用途。
  • BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
    申请人:SENOMYX, INC.
    公开号:US20160376263A1
    公开(公告)日:2016-12-29
    The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.
    本发明涵盖已知用于改变苦味感知的化合物和组合物,以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种:冷却剂;无活性药物成分;活性药用成分;食品添加剂或食品;调味剂或调味增强剂;食品或饮料产品;苦味化合物;甜味剂;苦味剂;酸味调味剂;咸味调味剂;鲜味调味剂;植物或动物产品;已知用于宠物护理产品中的化合物;已知用于个人护理产品中的化合物;已知用于家用产品中的化合物;制药制剂;局部制剂;大麻衍生或与大麻相关的产品;已知用于口腔护理产品中的化合物;饮料;香味、香或除臭剂;已知用于消费品中的化合物;化合物;磨料;表面活性剂;发热剂;吸烟物品;脂肪、油脂或乳化剂;和/或益生菌或补充剂。
  • GELLED HYDROCARBONS FOR OILFIELD PROCESSES, PHOSPHATE ESTER COMPOUNDS USEFUL IN GELLATION OF HYDROCARBONS AND METHODS FOR PRODUCTION AND USE THEREOF
    申请人:GHESNER IOAN
    公开号:US20110046408A1
    公开(公告)日:2011-02-24
    Phosphate esters useful for gelling hydrocarbons in combination with a metal source are disclosed along with methods of preparation of the phosphate esters. Fouling in oil refinery towers has been attributed due to distillation of impurities present in phosphate esters used to gel hydrocarbons for oil well fracturing. The improved method of preparation of the phosphate ester results in a product that substantially reduces or eliminates volatile phosphorus, which is phosphorus impurities that distill up to 250° C., and increases the high temperature viscosity of the hydrocarbon gels formed using the phosphate esters.
    磷酸酯与属源结合在一起用于凝胶化烃类物质,并公开了磷酸酯的制备方法。石油精炼塔中的结垢被归因于用于凝胶化油井压裂的磷酸酯中存在的杂质的蒸馏。改进的磷酸酯制备方法导致产品大幅减少或消除挥发性,即在250°C以下蒸馏的杂质,并增加使用磷酸酯形成的烃类凝胶的高温粘度。
  • [EN] METHODS OF TREATING LIPOSARCOMA<br/>[FR] PROCÉDÉS DE TRAITEMENT DU LIPOSARCOME
    申请人:INFINITY PHARMACEUTICALS INC
    公开号:WO2010135426A1
    公开(公告)日:2010-11-25
    Provided herein are methods of treating liposarcoma in a subject, the method comprising administering to the subject a therapeutically effective amount of an Hsp90 inhibitor.
    本文提供了一种治疗脂肪肉瘤的方法,该方法包括向受试者施用治疗有效量的Hsp90抑制剂
查看更多